Literature DB >> 6494428

Radiation survival properties of cultured vascular smooth muscle cells.

E M Rosen, I D Goldberg, K V Myrick, S Levenson.   

Abstract

Vascular injury has been suggested as a possible mechanism for late radiation damage to various organs. However, little is known about the radiobiology of cells of the blood vessel wall. We have studied the radiation survival properties of exponentially growing cultures of vascular smooth muscle cells. Medical smooth muscle cells were obtained from the thoracic aortas of 3- to 4-month-old Sprague-Dawley rats and were propagated in cell culture using standard techniques. Cultures from different strains were irradiated using 137Cs gamma radiation after varying periods in culture. Clonogenic survival was measured via colony formation assays. The mean D0 for seven survival curves utilizing four different strains of cells was 147 +/- 22 rad (range 117-176) and the mean extrapolation number (corrected for colony multiplicity) was 3.7 +/- 2.7 (range 1.1-9.5). Split dose survival assays demonstrated repair of sublethal radiation damage within the first 4 hr with recovery factors approximately equal to the extrapolation number. We conclude that rat aortic medial smooth muscle cells show moderate radiosensitivity similar to that measured in vitro for a variety of mammalian cell lines and in vivo for epithelial tissues in rodents.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6494428

Source DB:  PubMed          Journal:  Radiat Res        ISSN: 0033-7587            Impact factor:   2.841


  2 in total

Review 1.  [Intravascular irradiation in the combined therapy and prevention of restenosis. Overview].

Authors:  D Baumgart; U Quast; R Erbel
Journal:  Herz       Date:  1997-12       Impact factor: 1.443

2.  Postoperative electron beam radiotherapy for keloids: treatment outcome and factors associated with occurrence and recurrence.

Authors:  Sun Young Lee; Jin Park
Journal:  Ann Dermatol       Date:  2015-02-03       Impact factor: 1.444

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.